
Canada’s commissioner of competition intends to oppose Rogers Communications’s proposed $26-billion merger with Shaw Communications, the companies said in a statement released early Saturday.
The telecom giants said they were notified of the commissioner’s plan to file an application to the Competition Tribunal aimed at preventing the deal, following the close of trading on Friday.
They said they will oppose the application while “continuing to engage constructively with the Competition Bureau in an effort to bring this matter to a resolution.”
The companies said they remain committed to the planned merger and that it would be “in the best interests of Canada and Canadians because of the significant long-term benefits” for consumers, businesses and the economy.
When it announced the planned takeover in March 2021, Toronto-based Rogers said it would invest $2.5 billion on ramping up 5G networks in Western Canada over the next five years, following its acquisition of Calgary-based Shaw. Rogers also planned to establish a $1-billion fund dedicated to connecting rural, remote and Indigenous communities.
The Competition Bureau secured court orders in 2021 to help its investigations into the possible effects of the merger between the two communications companies. The takeover was also reviewed by several authorities, including the federal government and the Canadian Radio-television and Telecommunications Commission, which regulates the broadcasting and telecom industries.
To address concerns about any impact the deal would have on Canada’s wireless market, the companies have proposed full divestiture of Shaw’s wireless business, Freedom Mobile.
The deal would see Rogers acquire 16 cable services based in Western Canada, a national satellite television service and other broadcast and television services. The takeover would create Canada’s second-largest cellular and cable operator.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas